Loading...
01/11 03:35
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call shows a generally positive outlook with several key highlights: strong customer retention, increased gross margins, and an increase in bookings. While financial health revenue remained flat, patient care revenue showed growth. Management's confidence in maintaining consistent bookings and addressing retention issues is promising. The Q&A section reveals some concerns about client attrition and potential headwinds from new legislation, but the overall sentiment remains optimistic with strategic plans for growth and efficiency improvements.
Bookings $25.6 million on a TCV basis, compared to $22 million sequentially and $23 million year-over-year, showing a year-over-year increase. The increase is attributed to steady progress towards long-term goals.
Revenue $85.7 million, roughly flat compared to the prior year. Approximately $1 million of the year-over-year variance is due to the sunsetting of the Centriq product last year. Normalizing for this, revenue would have been up 1% versus the prior year.
Adjusted EBITDA $13.7 million, slightly ahead of the midpoint of expectations, with a margin of 16% compared to 15.7% last year. The improvement is driven by efficiencies and leverage in the business.
Free Cash Flow $5.5 million year-to-date, up $3.4 million compared to the first 6 months of 2024. The increase is due to improvements in working capital and cash flow conversion.
Accounts Receivable Improved by 5% and DSO improved by 4 days compared to the prior year. This improvement is attributed to better working capital management.
Leverage Ended the quarter at 2.4x, an improvement from 3.9x a year ago. This marks the second consecutive quarter where net leverage has been below 2.5x, driven by debt repayments totaling $32.5 million since January 2024.
Financial Health Revenue $54.3 million, relatively flat year-over-year. On a year-to-date basis, it grew 2.3%. The flat performance is due to slightly elevated levels of customer attrition and timing of some revenue in Q1.
Patient Care Revenue $31.4 million, increased approximately 1.1%. Excluding Centriq's contribution from last year's Q2, it would have grown almost 4%. The growth is attributed to cost optimization actions.
Gross Margins 52% in Q2, increased 250 basis points over last year. Financial Health gross margins were 46%, up 150 basis points, and Patient Care gross margins were 62%, up 400 basis points. The improvement is driven by offshoring initiatives and cost optimization actions.
CMS interoperability framework pledge: TruBridge signed the CMS interoperability framework pledge, emphasizing their commitment to empowering rural and community healthcare providers with real-time secure patient data access.
AI integration with Microsoft Dragon Copilot: TruBridge is collaborating with Microsoft to integrate Microsoft Dragon Copilot into their EHR solution, enhancing care delivery and operational efficiency for rural and community healthcare clients.
Expansion into India: TruBridge is establishing a physical presence in India by 2026 to standardize workflows, align with industry best practices, and enhance productivity and client satisfaction.
Larger hospital deals: TruBridge is moving upstream into larger hospitals, signing significant deals like the addition of 3 nTrust agreements, though these deals have longer implementation timelines.
Resource management improvements: TruBridge refined its resource model, paused global hiring temporarily, and invested in training programs to enhance talent and align resources effectively.
Offshoring initiatives: TruBridge is leveraging global offshoring, including a new office in India, to improve productivity, quality, and client satisfaction.
Leadership hires: New leadership hires include a Head of Services for Financial Health and a Head of India, focusing on operational efficiency and client service quality.
Focus on client retention: TruBridge identified client retention as a key area of improvement, implementing a strategic plan to enhance satisfaction and renewals.
AI-driven efficiency: Internally, TruBridge released an AI solution for patient care client support to standardize and improve response quality.
Client Retention Challenges: Client retention in the CBO side of the financial health business was slightly lower than forecasted, impacting revenue. Efforts to improve client satisfaction are ongoing, but this remains a multi-quarter challenge.
Delayed Revenue Recognition: Revenue recognition from larger bookings is delayed due to longer implementation timelines for sizable deals, some of which will not contribute to revenue until 2026.
Operational Delays: Progress in transformation initiatives is not always linear and involves delays, which could impact the achievement of long-term objectives.
Global Workforce Strategy: Temporary pause in global hiring and the establishment of a physical presence in India are part of efforts to streamline operations, but these changes may introduce short-term disruptions.
Economic Uncertainty: Clients are holding cash due to external policy uncertainties, which could impact accounts receivable and cash flow.
Leadership and Resource Management: Leadership changes and resource realignments are being implemented to address operational inefficiencies, but these adjustments may take time to yield results.
Regulatory and Compliance Risks: The company is actively working on remediation and strengthening of accounting processes and internal controls, indicating potential risks in compliance and financial reporting.
Revenue Guidance: The company has revised its full-year revenue guidance to a range of $345 million to $350 million, lowering the top end from the previous range of $345 million to $360 million. For Q3, revenue is expected to be between $85 million and $87 million.
Adjusted EBITDA Guidance: The full-year adjusted EBITDA guidance has been raised to a range of $62 million to $67 million, up from the previous range of $60 million to $66 million. For Q3, adjusted EBITDA is expected to be between $14 million and $16 million.
Profitability Expectations: The company expects an adjusted EBITDA margin of 18.5% at the midpoint of the full-year range, up from 17% in the previous guidance. The margin is expected to reach approximately 20% by year-end.
Client Retention and Revenue Recognition: Client retention in the CBO side of the Financial Health business was slightly lower than forecasted. Renewals are expected to improve significantly in 2026. Some large deals signed in Q1 and Q2 of 2025 will not contribute revenue until 2026 due to longer implementation timelines.
Operational Changes: The company is establishing a physical presence in India, targeting an opening in 2026, to enhance training, productivity, and client satisfaction. Leadership hires have been made to improve offshore service levels and operational efficiency.
AI and Technology Integration: The company is collaborating with Microsoft to integrate Microsoft Dragon Copilot into its EHR solution, with the integrated solution expected to be available in fall 2025. Internally, an AI solution has been released to improve client support efficiency.
The selected topic was not discussed during the call.
The earnings call indicates a negative sentiment due to several factors: decreased sand sales volumes and revenue, higher operating expenses, and economic uncertainties affecting completion activities. Although there's a share repurchase program, the overall financial performance is weak, with lower EBITDA and increased costs. The Q&A section reveals uncertainty in future guidance, further dampening sentiment. The revised revenue guidance and increased costs suggest a negative impact on the stock price in the short term.
The earnings call showed mixed results: improved cash flow and debt reduction are positives, but revenue growth is modest. The Q&A highlighted delays in bookings and uncertainties in Medicaid funding. While guidance was revised, the EBITDA outlook is stronger. However, the lack of specific guidance details and potential delays temper enthusiasm. Overall, the stock is likely to remain stable, reflecting a neutral sentiment.
The earnings call shows a generally positive outlook with several key highlights: strong customer retention, increased gross margins, and an increase in bookings. While financial health revenue remained flat, patient care revenue showed growth. Management's confidence in maintaining consistent bookings and addressing retention issues is promising. The Q&A section reveals some concerns about client attrition and potential headwinds from new legislation, but the overall sentiment remains optimistic with strategic plans for growth and efficiency improvements.
The earnings call reveals mixed signals: strong adjusted EBITDA growth and improved cash flow are positive, but concerns about tariffs, economic uncertainty, and workforce transition risks persist. The Q&A section highlights management's vague responses on cost savings and policy impacts, adding to uncertainty. Despite positive financial performance, lack of shareholder returns and unclear guidance on strategic initiatives balance the sentiment, leading to a neutral prediction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
